Scientists test new drug duo in fight against advanced cancers
NCT ID NCT01434316
Summary
This is an early-stage safety study to find the best dose and check the side effects of a two-drug combination (veliparib and dinaciclib) for patients with advanced solid tumors that have spread. The study involves 121 adults whose cancers have progressed despite standard treatments. The main goal is to see if the drugs can be safely given together and to learn how the body processes them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.